Phase I Study of Valproic Acid Given in Combination With Bevacizumab in Patients With Advanced Cancer to Determine Safety and Tolerability.

Trial Profile

Phase I Study of Valproic Acid Given in Combination With Bevacizumab in Patients With Advanced Cancer to Determine Safety and Tolerability.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Valproic acid
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Nov 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 16 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center
    • 02 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top